Abstract

Breakthrough T1D (formerly JDRF) is the leading global type 1 diabetes (T1D) research and advocacy organization. With a mission to accelerate life-changing breakthroughs to cure, prevent, and treat T1D and its complications, no organization does more to improve everyday life with T1D. Since its founding in 1970, Breakthrough T1D has committed more than $2.5 billion in research grants. Our research has 2 core objectives:
Cure T1D by restoring the body’s ability to make insulin and stopping T1D before it occurs or providing insulin independence through replacement with insulin-producing cells.
Improve lives by keeping people with T1D as healthy as possible until cures are found by advancing new T1D resources, technologies, and therapies.
Breakthrough T1D has had a hand in the development of nearly every T1D advancement over the past 50+ years and will continue to fund the best research until this disease is a thing of the past.
From the day of diagnosis to daily life decades later, Breakthrough T1D supports and connects people in the T1D community. While we drive toward curing T1D, we help make everyday life better for the people who face it. Whether you are interested in joining an educational summit, in need of advice from someone who has been there, or are looking for resources—to learn T1D basics, how to educate others about T1D, and where to find more information and support—Breakthrough T1D is ready to help, at any age or stage of T1D.
In addition to patient and community resources, Breakthrough T1D supports health care professionals with clinical guidance tools, accredited education, and more. Closing the gap between access to and adoption of T1D therapies is a mission priority for Breakthrough T1D. Our Medical Affairs unit focuses on:
Developing educational materials for health care professionals in the United States and around the world. Discover complementary resources available to health care professionals, including accredited education, here.
Empowering people with type 1 diabetes (T1D) to participate in shared decision-making with their health care teams about emerging T1D therapies.
Helping to establish and socialize clinical care guidelines tailored to regional needs.
Expanding clinical trial participation through community activation and health care professional education. Visit our Type 1 Diabetes Early Detection and Clinical Trials pages to learn more about these programs and how you can encourage participation among your patients.
Breakthrough T1D collaborates with ADCES at both the national and state levels. To connect with your local Breakthrough T1D chapter team, please complete this brief form. ■
